A trend of increased expression of IL-12β, and IL-15Rα was also observed on tumor-infiltrating CD8+T cells following bortezomib treatment compared to tumor-infiltrating CD8+T cells without bortezomib treatment (Figure 8D, 8E). The gene discussed is IL12B; the disease is neoplasm.